Related references
Note: Only part of the references are listed.Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity
Mathieu Uzzan et al.
NATURE MEDICINE (2022)
Extracellular vesicles-mediated interaction within intestinal microenvironment in inflammatory bowel disease
Qichen Shen et al.
JOURNAL OF ADVANCED RESEARCH (2022)
The significance of metalloproteinase 3 (MMP-3), chemokine CXC ligand 13 (CXCL-13) and complement component C5a in different stages of ANCA associated vasculitis
Aleksandra Rymarz et al.
SCIENTIFIC REPORTS (2021)
The Role of Extracellular Matrix Components in Inflammatory Bowel Diseases
Alicja Derkacz et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Metalloproteinases in Inflammatory Bowel Diseases
Martin Maronek et al.
JOURNAL OF INFLAMMATION RESEARCH (2021)
The molecular feature of macrophages in tumor immune microenvironment of glioma patients
Hao Zhang et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease
Vanessa Mitsialis et al.
GASTROENTEROLOGY (2020)
Novel Barbiturate-Nitrate Compounds Inhibit the Upregulation of Matrix Metalloproteinase-9 Gene Expression in Intestinal Inflammation through a cGMP-Mediated Pathway
Shane O'Sullivan et al.
BIOMOLECULES (2020)
Molecular Signature of Persistent Histological Inflammation in Ulcerative Colitis with Mucosal Healing
Mircea Manuc et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2020)
MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer
Jaslin P. James et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Crohn's disease: management in adults, children and young people - concise guidance
Gloria S. Z. Tun et al.
CLINICAL MEDICINE (2018)
Andecaliximab [Anti-matrix Metalloproteinase-9] Induction Therapy for Ulcerative Colitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2/ 3 Study in Patients With Moderate to Severe Disease
William J. Sandborn et al.
JOURNAL OF CROHNS & COLITIS (2018)
A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn's Disease
Stefan Schreiber et al.
JOURNAL OF CROHNS & COLITIS (2018)
Differential Intestinal Mucosa Transcriptomic Biomarkers for Crohn’s Disease and Ulcerative Colitis
Maria Dobre et al.
Journal of Immunology Research (2018)
Biochemical characterization and structure determination of a potent, selective antibody inhibitor of human MMP9
Todd C. Appleby et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis
W. J. Sandborn et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Shedding of Syndecan-1/CXCL1 Complexes by Matrix Metalloproteinase 7 Functions as an Epithelial Checkpoint of Neutrophil Activation
Sean E. Gill et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2016)
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
Karel G. M. Moons et al.
ANNALS OF INTERNAL MEDICINE (2015)
Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair
Giovanna Leoni et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Immunopathogenesis of IBD: current state of the art
Heitor S. P. de Souza et al.
Nature Reviews Gastroenterology & Hepatology (2015)
Differential diagnosis in inflammatory bowel disease colitis: State of the art and future perspectives
Gian Eugenio Tontini et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
MMP3 and CXCL1 are potent stromal protein markers of dysplasia-carcinoma transition in sporadic colorectal cancer
Ferenc Sipos et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2014)
East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort
J. Burisch et al.
GUT (2014)
Ulcerative colitis or Crohn's disease? Pitfalls and problems
Roger M. Feakins
HISTOPATHOLOGY (2014)
Increased expression of CXCR3 axis components and matrix metalloproteinase in pediatric inflammatory bowel disease patients
Keisuke Jimbo et al.
PEDIATRICS INTERNATIONAL (2014)
IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samples
Frency Varghese et al.
PLOS ONE (2014)
Phenotype of Inflammatory Bowel Disease at Diagnosis in the Netherlands: A Population-based Inception Cohort Study (the Delta Cohort)
Veerle J. A. A. Nuij et al.
INFLAMMATORY BOWEL DISEASES (2013)
Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair
Giovanna Leoni et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
European consensus on the histopathology of inflammatory bowel disease
F. Magro et al.
JOURNAL OF CROHNS & COLITIS (2013)
European evidence based consensus for endoscopy in inflammatory bowel disease
Vito Annese et al.
JOURNAL OF CROHNS & COLITIS (2013)
Identification of Novel Predictor Classifiers for Inflammatory Bowel Disease by Gene Expression Profiling
Trinidad Montero-Melendez et al.
PLOS ONE (2013)
The use of methotrexate for treatment of inflammatory bowel disease in clinical practice
Simone Saibeni et al.
DIGESTIVE AND LIVER DISEASE (2012)
Natural History of Pediatric-onset Inflammatory Bowel Disease A Systematic Review
Bincy P. Abraham et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Axel Dignass et al.
JOURNAL OF CROHNS & COLITIS (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Up-Regulation of Annexin-A1 and Lipoxin A4 in Individuals with Ulcerative Colitis May Promote Mucosal Homeostasis
Linda Vong et al.
PLOS ONE (2012)
Mucosal healing with methotrexate in Crohn's disease: a prospective comparative study with azathioprine and infliximab
D. Laharie et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Cytoscape 2.8: new features for data integration and network visualization
Michael E. Smoot et al.
BIOINFORMATICS (2011)
Common misconceptions about 5-aminosalicylates and thiopurines in inflammatory bowel disease
Javier P. Gisbert et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
A. Dignass et al.
JOURNAL OF CROHNS & COLITIS (2010)
Cellular sources of MMP-7, MMP-13 and MMP-28 in ulcerative colitis
Timo Rath et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Expression profiles of matrix metalloproteinases and their inhibitors in colonic inflammation related to pediatric inflammatory bowel disease
Laura Makitalo et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Aminosalicylates for induction of remission or response in Crohn's disease
Wee-Chian Lim et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
Annexin A1 and glucocorticoids as effectors of the resolution of inflammation
Mauro Perretti et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Annexin-1 modulates repair of gastric mucosal injury
Gary R. Martin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Activation of an IL-6:STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease
Rebecca Carey et al.
INFLAMMATORY BOWEL DISEASES (2008)
Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease
Subra Kugathasan et al.
NATURE GENETICS (2008)
Predicting a change in diagnosis from ulcerative colitis to Crohn's disease: a nested, case-control study
Gil Y. Melmed et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: A precancerous potential?
Timo Rath et al.
INFLAMMATORY BOWEL DISEASES (2006)
Change of diagnosis during the first five years after onset of inflammatory bowel disease: Results of a prospective follow-up study (the IBSEN Study)
Magne Henriksen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2006)
Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease
T Kirkegaard et al.
GUT (2004)
Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee
A Kornbluth et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Collagenase-1 (MMP-1), matrilysin-1 (MMP-7), and stromelysin-2 (MMP-10) are expressed by migrating enterocytes during intestinal wound healing
MT Salmela et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2004)
The immunological and genetic basis of inflammatory bowel disease
G Bouma et al.
NATURE REVIEWS IMMUNOLOGY (2003)
The expression of matrix metalloproteinase matrilysin indicates the degree of inflammation in ulcerative colitis
K Matsuno et al.
JOURNAL OF GASTROENTEROLOGY (2003)
Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation
MT Salmela et al.
GUT (2002)
Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis
KJ Newell et al.
MOLECULAR CARCINOGENESIS (2002)
Clinical aspects and pathophysiology of inflammatory bowel disease
BA Hendrickson et al.
CLINICAL MICROBIOLOGY REVIEWS (2002)
Vascular smooth muscle cells and pericytes express MMP-1, MMP-9, TIMP-1 and type I procollagen in inflammatory bowel disease
S Arihiro et al.
HISTOPATHOLOGY (2001)
Beneficial effects of Batimastat (BB-94), a matrix metalloproteinase inhibitor, in rat experimental colitis
P Di Sebastiano et al.
DIGESTION (2001)
Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease
RB Heuschkel et al.
GUT (2000)
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease
BG Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease
E Louis et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
Share Paper
